Literature DB >> 11586885

Monitoring activation of ribonuclease L by 2',5'-oligoadenylates using purified recombinant enzyme and intact malignant glioma cells.

L Rusch1, B Dong, R H Silverman.   

Abstract

A wide range of methods have been developed to study RNase L activation in cell-free systems and in intact cells. Many of the original methods were developed in the laboratory of I. Kerr in the early 1980s (e.g., see Knight et al.). Additional methods described in this article were developed or adapted from research in other fields after the cloning of RNase L and the appreciation of its role in apoptosis. These methods provide the basic techniques needed to induce RNase L activation in vitro and to measure some of its biological effects in living mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11586885     DOI: 10.1016/s0076-6879(01)42531-6

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  10 in total

Review 1.  RNase-L control of cellular mRNAs: roles in biologic functions and mechanisms of substrate targeting.

Authors:  Sarah E Brennan-Laun; Heather J Ezelle; Xiao-Ling Li; Bret A Hassel
Journal:  J Interferon Cytokine Res       Date:  2014-04       Impact factor: 2.607

2.  Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus.

Authors:  Ying Xiang; Richard C Condit; Sangeetha Vijaysri; Bertram Jacobs; Bryan R G Williams; Robert H Silverman
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

3.  A putative loop E motif and an H-H kissing loop interaction are conserved and functional features in a group C enterovirus RNA that inhibits ribonuclease L.

Authors:  Hannah L Townsend; Babal K Jha; Robert H Silverman; David J Barton
Journal:  RNA Biol       Date:  2008-10-09       Impact factor: 4.652

4.  A viral RNA competitively inhibits the antiviral endoribonuclease domain of RNase L.

Authors:  Hannah L Townsend; Babal K Jha; Jian-Qiu Han; N Karl Maluf; Robert H Silverman; David J Barton
Journal:  RNA       Date:  2008-04-21       Impact factor: 4.942

5.  Small-molecule activators of RNase L with broad-spectrum antiviral activity.

Authors:  Chandar S Thakur; Babal Kant Jha; Beihua Dong; Jaydip Das Gupta; Kenneth M Silverman; Hongxia Mao; Hiro Sawai; Akiko O Nakamura; Amiya K Banerjee; Andrei Gudkov; Robert H Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

6.  Hepatitis C virus RNA: dinucleotide frequencies and cleavage by RNase L.

Authors:  Christopher L Washenberger; Jian-Qiu Han; Katherina J Kechris; Babal Kant Jha; Robert H Silverman; David J Barton
Journal:  Virus Res       Date:  2007-07-02       Impact factor: 3.303

7.  A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the antiviral endoribonuclease RNase L.

Authors:  Jian-Qiu Han; Hannah L Townsend; Babal Kant Jha; Jayashree M Paranjape; Robert H Silverman; David J Barton
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

8.  Evasion of antiviral innate immunity by Theiler's virus L* protein through direct inhibition of RNase L.

Authors:  Frédéric Sorgeloos; Babal Kant Jha; Robert H Silverman; Thomas Michiels
Journal:  PLoS Pathog       Date:  2013-06-27       Impact factor: 6.823

9.  Enzyme assays for synthesis and degradation of 2-5As and other 2'-5' oligonucleotides.

Authors:  Jesper Buchhave Poulsen; Karina Hansen Kjær; Just Justesen; Pia Møller Martensen
Journal:  BMC Biochem       Date:  2015-06-26       Impact factor: 4.059

10.  Ribonuclease L and metal-ion-independent endoribonuclease cleavage sites in host and viral RNAs.

Authors:  Daphne A Cooper; Babal K Jha; Robert H Silverman; Jay R Hesselberth; David J Barton
Journal:  Nucleic Acids Res       Date:  2014-02-05       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.